RLI heads into its May 14 earnings release with short sellers accelerating bets against the stock at the sharpest pace in months — even as insider buying from the CEO and COO back in January told a very different story.
The short-side pressure is the standout signal heading into the print. Short interest has climbed 27% over the past month to 5.8% of the free float — a meaningful level for an insurance name that historically trades with low short conviction. The jump accelerated sharply this week, with a 13% single-day surge on May 11 alone. Despite that buildup, the borrow market remains relaxed: cost to borrow is just 0.44%, and availability is wide. There is no sign of a squeeze dynamic in the lending pool. This looks more like fresh directional bets than any technical pressure.
The price action explains why bears are showing up. RLI has fallen 16% over the past month to $48.53, dramatically underperforming close peers CB and HIG, which shed just 1.5% and 1.3% over the week. is nearly flat on the week. RLI's slide stands apart from the broader P&C insurance group. Meanwhile, the ORTEX short score ticked up to 53 on May 11, its highest reading of the past two weeks, reflecting the recent momentum shift.
The bull and bear debate centres on whether the company's E&S (Excess and Surplus) casualty growth — submissions up 20% last quarter — can offset a deteriorating property segment. Bears point to a 2% drop in gross written premiums and an 11% decline in the Property segment, alongside reserve concerns tied to elevated loss development in the 2021–2022 accident years. The 46% drop in premium per policy in Florida's E&S market compounds the picture. Bulls counter that Surety and casualty distribution momentum remain intact and that RLI's niche underwriting model has historically navigated hard markets well. The analyst community has been trimming targets: Wells Fargo and Keefe, Bruyette & Woods both cut price targets in early April while holding their ratings. The consensus mean target of $57.75 implies meaningful upside from current levels — but EPS momentum is near the bottom of the universe (17th percentile on 30-day momentum, 16th on 90-day), suggesting forward estimates are still under pressure.
The most intriguing data point, perhaps, is the insider register. In January, CEO Craig Kliethermes bought 5,000 shares at $57.45 and COO Jennifer Klobnak added 2,000 at $57.99. Those open-market purchases — totalling over $400,000 — came at prices well above the current level. Against that backdrop, Wednesday's print will test whether the property segment deterioration has stabilised, and whether the casualty book's growth rate justifies a re-rating back toward the Street's consensus.
See the live data behind this article on ORTEX.
Open RLI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
